Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 10019-957

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 10019-957). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide Structural Formula (Image 01)

Chemical structure diagram of cyclophosphamide, showing its molecular arrangement including a cyclic moiety, phosphorus atom, and other functional groups as labeled.*

FDA Label Image

Cyclophosphamide Representative Container Label Ndc 10019-955-50 (Image 02)

Label for Cyclophosphamide for Injection, USP 500 mg/vial, a cytotoxic agent by Baxter Healthcare Company. It states the product is for single dose use, sterile, non-pyrogenic, and for parenteral use. Instructions for infusion or direct injection dilution with 25 mL of appropriate sterile solution are noted. Storage instructions and regulatory references are included.*

FDA Label Image

Cyclophosphamide Representative Carton Label Ndc 10019-955-01 1 Of 2 (Image 03)

Packaging label for Cyclophosphamide injection, USP, 500 mg per vial, manufactured by Baxter Healthcare Company. The label indicates it is for intravenous or direct injection use, single-dose vial, requiring dilution before use. Storage instructions and cytotoxic agent warnings are included. The product is sterile and non-pyrogenic for parenteral use.*

FDA Label Image

Cyclophosphamide Representative Carton Label Ndc 10019-955-01 2 Of 2 (Image 04)

Cyclophosphamide for Injection, USP 500 mg per vial is shown on a cardboard carton label. The label states the drug must be diluted for intravenous infusion or can be used for direct injection. It is a single-dose vial manufactured by Baxter Healthcare Corporation, Deerfield, IL, made in Germany. The NDC is 10019-955-01.*

FDA Label Image

Cyclophosphamide Representative Container Label Ndc 10019-956-16 (Image 05)

Label for Cyclophosphamide for Injection, USP, 1 gram per vial, a cytotoxic agent for single dose use, sterile and non-pyrogenic for parenteral administration. The label indicates it is manufactured by Baxter Healthcare Company. Instructions for reconstitution with sterile water or sodium chloride injection for intravenous or direct injection use are included.*

FDA Label Image

Cyclophosphamide Representative Carton Label Ndc 10019-956-01 1 Of 2 (Image 06)

Packaging label for Cyclophosphamide for Injection, USP, 1 gram per vial, powder for solution. The label indicates the drug is for intravenous or direct injection use and must be diluted prior to infusion. It is a single-dose vial labeled as prescription only (Rx only). The labeler is Baxter Healthcare Company, with manufacturing in Germany. The label includes storage instructions and warnings emphasizing its cytotoxic agent properties and sterile, non-pyrogenic status for parenteral use.*

FDA Label Image

Cyclophosphamide Representative Carton Label Ndc 10019-956-01 2 Of 2 (Image 07)

Packaging label for Cyclophosphamide for Injection, USP 1 gram per vial by Baxter Healthcare Company. The label specifies that the vial is single-dose, must be diluted for IV infusion or used for direct injection. Manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA, made in Germany. The label includes NDC 10019-956-01 and the statement Rx only.*

FDA Label Image

Cyclophosphamide Representative Container Label Ndc 10019-957-11 (Image 08)

Label for Cyclophosphamide for Injection, USP, 2 gram per vial, sterile powder for solution. The label indicates the product is a cytotoxic agent for single dose use, non-pyrogenic, for parenteral use. It includes instructions for IV infusion and direct injection preparation. The labeler is Baxter Healthcare Company, manufactured in Germany.*

FDA Label Image

Cyclophosphamide Representative Carton Label Ndc 10019-967-01 1 Of 2 (Image 09)

Cyclophosphamide for Injection, USP 2 gram/vial powder for solution single dose vial packaging label. The label includes dosing instructions for IV infusion and direct injection, storage conditions, and cytotoxic agent warnings. Manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Cyclophosphamide Representative Carton Label Ndc 10019-967-01 2 Of 2 (Image 10)

The image shows the carton label for Cyclophosphamide for Injection, USP, 2 gram per vial. The label indicates the product is a single dose vial that must be diluted for intravenous infusion or direct injection use. It is labeled with NDC 10019-957-01 and is manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA, made in Germany. The carton also features a barcode and a recycling symbol for the folding box.*

FDA Label Image

Image 11

Label for Cyclophosphamide for Injection, USP 500 mg by Baxter Healthcare Company. The label indicates storage instructions, packaging as 120 packs each containing 1 single-dose vial of 500 mg, and includes expiration and lot number fields, along with barcodes and the NDC 10019-955-01.*

FDA Label Image

Image 12

Label for Cyclophosphamide for Injection, USP 500 mg, provided by Baxter Healthcare Company. The package contains 120 packs, each with one 500 mg single dose vial. Storage instructions specify to keep at or below 25°C (77°F). The label includes lot and expiration placeholders, barcodes, and the Baxter product code and NDC 10019-955-01.*

FDA Label Image

Image 13

Cyclophosphamide for Injection USP 1 g powder for solution label from Baxter Healthcare Company. The label includes storage instructions at or below 25°C, packaging info with 120 packs each containing one 1 g single dose vial, and barcode elements. The label also lists the manufacturer location in Deerfield, IL, USA.*

FDA Label Image

Image 14

Cyclophosphamide for Injection, USP 1 g powder for solution label from Baxter Healthcare Company. The label includes storage instructions at or below 25°C (77°F) and packaging information of 120 packs, each containing one 1 g single-dose vial. The label shows expiration date, lot number, barcodes, and the NDC number 10019-956-01.*

FDA Label Image

Image 15

Packaging label for Cyclophosphamide for Injection, USP 2 g powder for solution by Baxter Healthcare Company. The label indicates 60 packs of single dose vials containing 2 g each. It includes storage information, manufacturer details, lot and expiration date fields, and multiple barcodes including the NDC number 10019-957-01.*

FDA Label Image

Image 16

Label for Cyclophosphamide for Injection, USP 2 g, by Baxter Healthcare Company. The label indicates storage at or below 25°C (77°F) and packaging as 60 packs, each containing one 2 g single-dose vial. It includes the NDC 10019-957-01 and manufacturer information for Baxter Healthcare Corporation in Deerfield, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.